Lineage Cell Therapeutics (LCTX) Tax Rate (2014 - 2023)

Lineage Cell Therapeutics (LCTX) reported Tax Rate of 29.05% for Q1 2023, up 153.91% quarter-over-quarter from 11.44% in Q3 2021.

Lineage Cell Therapeutics (LCTX) Tax Rate (2014 - 2023) Analysis & Trends

Lineage Cell Therapeutics has reported Tax Rate for 4 years, with the latest figure at 29.05% in Q1 2023.

For the quarter ending Q1 2023, Tax Rate changed N/A year-over-year to 29.05%; the trailing twelve-month figure through Dec 2023 stood at 7.74% (down 4657.0% YoY), and the FY2025 full-year result was 7.69%, changed N/A from the prior year.
Tax Rate for Q1 2023 stood at 29.05%, up from 11.44% in the prior quarter.
The five-year high for Tax Rate was 262.3% in Q4 2019, with the low at 5.71% in Q3 2019.
Historically, Tax Rate has averaged 50.96% across 3 years, with a median of 12.0% in 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-57.14
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-6.79
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	5.61
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	17.68
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Lineage Cell Therapeutics	303.84 Mn	239.94 Mn	1.73 Mn	-

Download Data